Perceptive Advisors’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
Perceptive Advisors's BLSM Position: Q3 2026 in Review
Perceptive Advisors opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 1,812,193 shares worth $33.8M. The stake represents 0.59% of the portfolio and ranks #34 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- Perceptive Advisors held 1,812,193 shares of BlossomHill Therapeutics worth $33.8M as of Q3 2026.
- BlossomHill Therapeutics was a new Perceptive Advisors position in Q3 2026.
- BlossomHill Therapeutics made up 0.59% of Perceptive Advisors's portfolio in Q3 2026, its #34 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on Perceptive Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.